MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.

Front Cardiovasc Med · 2021 · PMC8762055 · PMID 35047575

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Gastric administration of resveratrol showed a trend to alleviate lipid deposition in both NC-shRNA-AAV1 and mef2a-shRNA-AAV1 ( Supplementary Figures 4A-1,B-1 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.